19 Nov 2012 12:19
RNS Number : 4568R
ValiRx PLC
19 November 2012
19 November 2012
VALIRX PLC
("ValiRx" or the "Company")
RESULT OF GENERAL MEETING
ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the General Meeting of the Company held earlier today, all resolutions were duly passed.
Enquires:
ValiRx plc | Tel: +44 (0) 20 3008 4416 |
Dr Satu Vainikka | www.ValiRx.com |
|
|
Cairn Financial Advisers LLP (Nominated Adviser) | Tel:+44 (0) 20 7148 7900 |
Liam Murray / Avi Robinson |
|
|
|
Hybridan LLP (Broker) | Tel: +44 (0) 20 7947 4350 |
Claire Noyce / Deepak Reddy |
|
|
|
Peckwater PR | Tel: +44 (0)7879 458 364 |
Tarquin Edwards | tarquin.edwards@peckwaterpr.co.uk |
This information is provided by RNS
The company news service from the London Stock Exchange
ValiRx (VAL)